We used a previously described biodegradable dry powder, PLGA microsphere, synthetic vaccine platform adjuvanted with TLR-4 and TLR-9 ligands [37] to immunize C57BL/6 mice with NP43-53 11-mer, the CTL+ class I peptide antigen from the Ebola Ziare NP protein identified by Wilson et al [59] . 